SFM
TRAW icon

Sphera Funds Management’s Traws Pharma TRAW Stock Holding History

Sphera Funds Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
+398,486
New +$549K 0.04% 102
2014
Q1 		– Sell
-2
Closed -$1.38M – 138
2013
Q4 		$1.38M Buy
+2
New +$1.89M 0.38% 62

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Sphera Funds Management's TRAW Position: Q2 2026 in Review

Sphera Funds Management opened a new position in Traws Pharma (TRAW) in Q2 2026: 398,486 shares worth $336K. The stake represents 0.04% of the portfolio and ranks #102 among its holdings. This is a return to the name: Sphera Funds Management previously reported a position in TRAW as recently as Q4 2013.

Sphera Funds Management first reported a position in TRAW in Q4 2013 and has held it in 2 quarters since. The position peaked at $1.38M in Q4 2013. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Sphera Funds Management held 398,486 shares of Traws Pharma worth $336K as of Q2 2026.
  • Traws Pharma was a new Sphera Funds Management position in Q2 2026.
  • Traws Pharma made up 0.04% of Sphera Funds Management's portfolio in Q2 2026, its #102 holding.
  • Sphera Funds Management first reported a position in Traws Pharma in Q4 2013 and has held it in 2 quarters since.
  • Sphera Funds Management's Traws Pharma position peaked at $1.38M in Q4 2013.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.